High Throughput Screening (HTS) Market to Hit $47.41 Billion by 2031

1. "High Throughput Screening (HTS) Market to Hit $47.41 Billion by 2031” J

2. High Throughput Screening (HTS) Market 2024-2031 Meticulous Research®, a global leader in market intelligence, has released a new report on the High Throughput Screening (HTS) market, forecasting its valuation to reach $47.41 billion by 2031, growing at a 10.1% CAGR from 2024 to 2031. Download Sample Report Here Market Drivers and Challenges The report highlights several factors driving the market’s rapid expansion. Key contributors include: • Widespread adoption of advanced screening technologies by pharmaceutical and biotechnology companies • Increased funding for drug discovery programs • A growing number of drug targets and expanding HTS facilities Despite these favorable trends, the market faces challenges, including high capital investment requirements and evolving government regulations governing drug development. Emerging Trends and Opportunities The report identifies several emerging trends that are reshaping the HTS market landscape: • Multiplexed assays and miniaturization of HTS technologies • Artificial intelligence (AI) integration in screening processes • Growth of Ultra-High-Throughput Screening (uHTS) and organ-on-chip technologies These innovations are unlocking new opportunities, particularly in fast-growing biotechnology hubs like India and Singapore. However, the industry must also address challenges such as complex data management and false positive results, which could slow adoption. Key Segment Insights 1. Consumables and Reagents: This segment is expected to dominate the market in 2024, driven by advancements in kit development, the wide availability of reagents, and frequent use of consumables in HTS processes. 2. Technologies – Cell-based Assays: Among technologies, cell-based assays, especially 3D cell cultures, are projected to hold the largest share. 3D cultures’ ability to closely replicate organ microarchitecture allows for more accurate in vivo studies and better predictive drug responses, boosting their adoption. 3. Applications – Target Identification: Target identification is forecasted to be the largest application segment in 2024, reflecting increased investments in drug discovery. As pharmaceutical companies face the high costs of drug development, they are prioritizing early-stage discovery efforts to accelerate time-to-market. 4. End Users – Pharmaceutical and Biotechnology Companies: The pharmaceutical and biotech industries will remain the largest end-users, thanks Page 1 of 3 © Meticulous Research| sales@meticulousresearch.com

3. High Throughput Screening (HTS) Market 2024-2031 to rising investments in research laboratories and R&D funding. For example, the National Institutes of Health (NIH) increased its funding from $42 billion in 2021 to $45 billion in 2022, signaling strong industry support for innovation. Regional Analysis The report offers a detailed regional outlook, covering North America, Europe, Asia- Pacific, Latin America, and the Middle East & Africa. • Asia-Pacific is expected to register the highest CAGR, with China leading the charge. Factors such as surging R&D investments and a rise in drug discovery activities are driving this growth. Notably, China achieved record approvals for investigational new drug (IND) and new drug applications (NDA) in the first quarter of 2022, highlighting its growing influence in the pharmaceutical space. Quick Buy Here About Meticulous Research® Founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013, Meticulous Research® has emerged as a trusted provider of premium market intelligence across major global markets. True to its name, Meticulous Research® excels in highly detailed primary and secondary research methodologies. With a skilled team of analysts and robust data collection capabilities, the company offers a range of services, including: • Syndicated research reports • Custom market studies • Consulting solutions • Quick-turnaround research for critical business needs Meticulous Research® operates across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, serving companies with data-driven insights for sustainable growth. Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 2 of 3 © Meticulous Research| sales@meticulousresearch.com

4. High Throughput Screening (HTS) Market 2024-2031 Page 3 of 3 © Meticulous Research| sales@meticulousresearch.com